DIRECT MEDICAL COST ANALYSIS OF PERCUTANEOUS CORONARY INTERVENTION IN ACUTE CORONARY SYNDROME PATIENTS

Ngọc Dung Phạm, Hoàng Lan Anh Bùi, Thị Thùy Linh Phạm, Minh Trạng Bùi, Chí Thanh Nguyễn

Main Article Content

Abstract

Acute Coronary Syndrome (ACS) is one of the leading cardiovascular diseases causing death in developed and developing countries, including Vietnam. Coronary intervention is a common treatment method for ACS, but it has high treatment costs that cause a significant economic burden for individuals and the health system. The study was conducted using a cross-sectional descriptive design based on medical records of ACS patients at the Ho Chi Minh City Heart Institute that met the sampling criteria during the sampling period. The survey of 146 medical records that met the criteria revealed that the average direct medical cost was 84.861.931 VND (95% CI: 73.390.073 – 96.333.789 VND). In the structure of direct medical costs, costs of medical supplies and diagnostic imaging account for the highest proportion (66% and 22%, respectively). Health insurance coverage is the same as what patients pay (51%) and 48%, respectively. In patients with acute coronary syndrome, the duration of treatment is associated with the cost of coronary intervention treatment.

Article Details

References

1. D. M. AHMED, "Acute Coronary Syndrome – Explained By A Cardiologist," MyHeart.net, no. April 9, 2018. [Online]. Available: https://my heart.net/articles/acute-coronary-syndrome-explained-by-a-cardiologist/.
2. W. H. Organization, "Cardiovascular-disease," 2023. [Online]. Available: https://www.who.int/ vietnam/vi/health-topics/cardiovascular-disease.
3. Q. V. Nguyễn and V. T. Ngô, "đặc điểm lâm sàng, cận lâm sàng, kết quả điều trị bệnh nhân nhồi máu cơ tim cấp dưới 40 tuổi," Tạp chí Y Dược học Cần Thơ, no. 59, pp. 33-38, 05/31 2023, doi: 10.58490/ctump.2023i59.1622.
4. S. Wang, Petzold, M., Cao, J., Zhang, Y., & Wang, W., "Direct medical costs of hospitalizations for cardiovascular diseases in Shanghai, China: trends and projections," Medicine, vol. 20, 94, p. 837, 2015, doi: https://doi.org/10.1097/MD.0000000000000837.
5. S. Sheikhgholami, F. Ebadifardazar, A. Rezapoor, M. Tajdini, and M. Salarifar, "Social and Economic Costs and Health-Related Quality of Life in Patients With Acute Coronary Syndrome," (in English), Value in Health Regional Issues, Article vol. 24, pp. 123-129, 2021, doi: 10.1016/j.vhri.2020.11.002.
6. Z. Zhao and M. Winget, "Economic burden of illness of acute coronary syndromes: medical and productivity costs," (in eng), BMC Health Serv Res, vol. 11, p. 35, Feb 14 2011, doi: 10.1186/1472-6963-11-35.
7. K. S. Coyne, C. Paramore, S. Grandy, M. Mercader, M. Reynolds, and P. J. V. i. H. Zimetbaum, "Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States," vol. 9, no. 5, pp. 348-356, 2006.